about
Neuropsychiatric consequences of cardiovascular medicationsSpecial considerations in the treatment of patients with bipolar disorder and medical co-morbiditiesA 6-month large-scale study into the safety of tamsulosinPhosphatidylinositol 3-Kinase/AKT Pathway Inhibition by Doxazosin Promotes Glioblastoma Cells Death, Upregulation of p53 and Triggers Low NeurotoxicityManagement of and counseling for psychotropic drug-induced sexual dysfunction.Novel role for alpha1-adrenergic receptor subtypes in lower urinary tract symptoms.Alpha-blockers and lower urinary tract function: more than smooth muscle relaxation?Urethral pressure profile and hemodynamic effects of phenoxybenzamine and prazosin in non-sedated male beagle dogs.Orthostatic hypotension induced by postural change in the rat (tilt test).Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents.Preparation and in vivo evaluation of spray dried matrix type controlled-release microparticles of tamsulosin hydrochloride for orally disintegrating tablet.A prospective pilotstudy comparing the anesthetic effects of an alpha-2 agonist during holmium laser resection of the prostate and transurethral resection for prostate surgery for benign prostatic hyperplasia patients using selective alpha-1 blockers
P2860
Q24635624-0E3557BF-C18F-4CBE-B914-E8EEEBF9378DQ24806762-FD11075C-755A-40A1-BC4A-BB3E1D178BC8Q28367575-E15A7AB9-6365-4434-8CD5-752E5D7AB1DDQ28551654-F063F481-6578-4F55-9512-1F3DDFDC67B0Q33693819-46D2B651-8E5C-4120-AF61-280709363809Q34334924-6AAE4616-8A2E-42F1-8FD7-E516EF8AC001Q34334931-061C7115-0F25-4A34-A5F2-8EECBA1CBAB3Q36501500-F8C0B1F0-9ECF-4404-9632-9DF98CF5B690Q42721767-492182FA-BED3-4FA2-AC0B-CABED3788966Q48372657-BEF3EBB3-F293-4BCD-A501-CEA48D4B2E55Q52684757-A7B04328-E772-4995-AC35-FF02443ECE0FQ53393428-45FB3C0D-9A25-4EAE-9907-63BE6D5DF56CQ59128742-EB19D751-2A9F-4C9C-B695-D795644BEF71
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Adverse effects of alpha 1-adrenergic blocking drugs.
@ast
Adverse effects of alpha 1-adrenergic blocking drugs.
@en
type
label
Adverse effects of alpha 1-adrenergic blocking drugs.
@ast
Adverse effects of alpha 1-adrenergic blocking drugs.
@en
prefLabel
Adverse effects of alpha 1-adrenergic blocking drugs.
@ast
Adverse effects of alpha 1-adrenergic blocking drugs.
@en
P1433
P1476
Adverse effects of alpha 1-adrenergic blocking drugs.
@en
P2093
S G Carruthers
P356
10.2165/00002018-199411010-00003
P577
1994-07-01T00:00:00Z
P6179
1039032370